Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common antineuronal antibody encephalitis in autoimmune encephalitis found at present. It has complex clinical manifestations such as psychiatric and behavioral abnormalities, seizures, movement disorders, consciousness, and autonom...
Main Authors: | Hao Wang, Zheng Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/7506590 |
Similar Items
-
Autoimmune N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: An important differential diagnosis for viral encephalitis
by: N. Nghiem My
Published: (2020-12-01) -
Anti-N-Methyl-d-Aspartate receptor (NMDAR) encephalitis during pregnancy: Clinical analysis of reported cases
by: Yan-Chao Shi, et al.
Published: (2017-06-01) -
The first case of Anti-N-methyl-d-aspartate receptor encephalitis (Anti-NMDAR encephalitis) associated with ovarian mucinous cystadenoma: A case report
by: Eun Hye Cho, et al.
Published: (2019-07-01) -
Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
by: Min Zhang, et al.
Published: (2019-06-01) -
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
by: Te-Yu Hung, et al.
Published: (2011-12-01)